A review of squamous cell carcinoma arising in mature cystic teratoma of the ovary

被引:19
作者
Abhilasha, N. [1 ]
Bafna, U. D. [1 ]
Pallavi, V. R. [1 ]
Rathod, P. S. [1 ]
Krishnappa, S. [1 ]
机构
[1] Kidwai Mem Inst Oncol, Dept Gynaecol Oncol, Bangalore, Karnataka, India
关键词
Mature cystic teratoma; ovary; squamous cell carcinoma; MALIGNANT-TRANSFORMATION; DERMOID CYSTS; BENIGN; ANTIGEN; PACLITAXEL;
D O I
10.4103/0019-509X.204763
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
INTRODUCTION: Germ cell tumors account for 20-25% of ovarian neoplasms. Mature cystic teratoma (MCT) is the most common ovarian germ cell tumor. Malignancy in MCT is seen in 1-2% of the cases. Squamous cell carcinoma (SCC) accounts for 80% of the cases and carries a poor prognosis. AIM: To study the clinicopathological factors, management protocols and its outcome. MATERIALS AND METHODS: Case records reviewed from August 2006 to August 2011 at our institute identified 10 women with SCC in ovarian MCT. Staging was done according to FIGO 2009 guidelines. Primary surgery followed by adjuvant treatment with platinum based chemotherapy was given. RESULTS: Median age was 53.5 years. Six out of 10 patients were postmenopausal and aged above 50 years. Abdominal pain and abdominal mass were the most common presenting symptoms. According to FIGO: Two in stage 1, five in stage 2, two in stage 3 and one in stage 4. Among six optimally cytoreduced patients, five (83%) had no evidence of disease with a median follow up of 10 months. Whereas all four (100%) suboptimally cytoreduced patients had progressive disease within 3 to 4 months of primary surgery despite chemotherapy. CONCLUSION: Squamous cell carcinoma in MCT of ovary is a rarity. It carries a poor prognosis, especially in advanced stages and suboptimally cytoreduced patients. Platinum with or without taxane based chemotherapy may be useful as adjuvant treatment. However, further studies and standardization of treatment protocols are required for any recommendations.
引用
收藏
页码:612 / 614
页数:3
相关论文
共 22 条
[1]   SQUAMOUS-CELL NEOPLASMS ARISING FROM OVARIAN BENIGN CYSTIC TERATOMA [J].
AMERIGO, J ;
NOGALES, FF ;
FERNANDEZSANZ, J ;
OLIVA, H ;
VELASCO, A .
GYNECOLOGIC ONCOLOGY, 1979, 8 (03) :277-283
[2]  
Emoto M, 2000, CANCER, V88, P2298, DOI 10.1002/(SICI)1097-0142(20000515)88:10<2298::AID-CNCR14>3.0.CO
[3]  
2-S
[4]   Squamous-cell carcinoma in mature cystic teratoma of the ovary: systematic review and analysis of published data [J].
Hackethal, Andreas ;
Brueggmann, Doerthe ;
Bohlmann, Michael K. ;
Franke, Folker E. ;
Tinneberg, Hans-Rudolf ;
Muenstedt, Karsten .
LANCET ONCOLOGY, 2008, 9 (12) :1173-1180
[5]   CLINICOPATHOLOGIC STUDY OF SQUAMOUS-CELL CARCINOMA OF THE OVARY [J].
KASHIMURA, M ;
SHINOHARA, M ;
HIRAKAWA, T ;
KAMURA, T ;
MATSUKUMA, K .
GYNECOLOGIC ONCOLOGY, 1989, 34 (01) :75-79
[6]   Dermoid cysts of the ovary with malignant transformation: MR appearance [J].
Kido, A ;
Togashi, K ;
Konishi, I ;
Kataoka, ML ;
Koyama, T ;
Ueda, H ;
Fujii, S ;
Konishi, J .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1999, 172 (02) :445-449
[7]   Squamous cell carcinoma arising from mature cystic teratoma of the ovary: A clinicopathologic analysis [J].
Kikkawa, F ;
Ishikawa, H ;
Tamakoshi, K ;
Nawa, A ;
Suganuma, N ;
Tomoda, Y .
OBSTETRICS AND GYNECOLOGY, 1997, 89 (06) :1017-1022
[8]  
KIMURA T, 1989, CANCER-AM CANCER SOC, V64, P480, DOI 10.1002/1097-0142(19890715)64:2<480::AID-CNCR2820640222>3.0.CO
[9]  
2-7
[10]  
KRUMERMAN MS, 1977, CANCER-AM CANCER SOC, V39, P1237, DOI 10.1002/1097-0142(197703)39:3<1237::AID-CNCR2820390332>3.0.CO